IR@PKUHSC  > 北京大学基础医学院  > 细胞生物学系
学科主题基础医学
LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling
Li, L.; Wei, X. H.; Pan, Y. P.; Li, H. C.; Yang, H.; He, Q. H.; Pang, Y.; Shan, Y.; Xiong, F. X.; Shao, G. Z.; Zhou, R. L.
关键词Laptm4b Multidrug Resistance Drug Efflux Pi3k-akt Signaling
刊名ONCOGENE
2010-10-01
DOI10.1038/onc.2010.303
29期:43页:5785-5795
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemistry & Molecular Biology ; Oncology ; Cell Biology ; Genetics & Heredity
研究领域[WOS]Biochemistry & Molecular Biology ; Oncology ; Cell Biology ; Genetics & Heredity
关键词[WOS]HEPATOCELLULAR-CARCINOMA ; P-GLYCOPROTEIN ; DRUG-RESISTANCE ; TETRATRANSMEMBRANE PROTEIN ; SACCHAROMYCES-CEREVISIAE ; MEMBRANE-PROTEIN ; CELLS ; EXPRESSION ; OVEREXPRESSION ; PROGRESSION
英文摘要

LAPTM4B (lysosomal protein transmembrane 4 beta) is a newly identified cancer-associated gene. Both of its mRNA and the encoded LAPTM4B-35 protein are significantly upregulated with more than 70% frequency in a wide variety of cancers. The LAPTM4B-35 level in cancer is evidenced to be an independent prognostic factor and its upregulation promotes cell proliferation, migration and invasion, as well as tumorigenesis in nude mice. In contrary, knockdown of LAPTM4B-35 expression by RNA interference (RNAi) reverses all of the above malignant phenotypes. We herein reveal a new role of LAPTM4B-35 in promoting multidrug resistance of cancer cells. Upregulation of LAPTM4B-35 motivates multidrug resistance by enhancement of efflux from cancer cells of a variety of chemodrugs with variant structures and properties, including doxorubicin, paclitaxel and cisplatin through colocalization and interaction of LAPTM4B-35 with multidrug resistance (MDR) 1 (P-glycoprotein, P-gp), and also by activation of PI3K/AKT signaling pathway through interaction of PPRP motif contained in the N-terminus of LAPTM4B-35 with the p85 alpha regulatory subunit of PI3K. The specific inhibitors of PI3K and knockdown of LAPTM4B-35 expression by RNAi eliminate the multidrug resistance effect motivated by upregulation of LAPTM4B-35. In conclusion, LAPTM4B-35 motivates multidrug resistance of cancer cells by promoting drug efflux through colocalization and interaction with P-gp, and anti-apoptosis by activating PI3K/AKT signaling. These findings provide a promising novel strategy for sensitizing chemical therapy of cancers and increasing the chemotherapeutic efficacy through knockdown LAPTM4B-35 expression by RNAi. Oncogene (2010) 29, 5785-5795; doi: 10.1038/onc.2010.303; published online 16 August 2010

语种英语
WOS记录号WOS:000283586200004
项目编号2006AA02A305 ; H020220020310 ; 90408018
资助机构211 and 985 Foundation of Peking University ; National High-tech R&amp ; D Program (863 Program) ; 248 major R&amp ; D program of Beijing ; NNSFC
引用统计
被引频次:70[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55387
专题北京大学基础医学院_细胞生物学系
作者单位Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Li, L.,Wei, X. H.,Pan, Y. P.,et al. LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling[J]. ONCOGENE,2010,29(43):5785-5795.
APA Li, L..,Wei, X. H..,Pan, Y. P..,Li, H. C..,Yang, H..,...&Zhou, R. L..(2010).LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.ONCOGENE,29(43),5785-5795.
MLA Li, L.,et al."LAPTM4B: A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling".ONCOGENE 29.43(2010):5785-5795.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
LAPTM4B_ A novel can(956KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, L.]的文章
[Wei, X. H.]的文章
[Pan, Y. P.]的文章
百度学术
百度学术中相似的文章
[Li, L.]的文章
[Wei, X. H.]的文章
[Pan, Y. P.]的文章
必应学术
必应学术中相似的文章
[Li, L.]的文章
[Wei, X. H.]的文章
[Pan, Y. P.]的文章
相关权益政策
暂无数据
收藏/分享
文件名: LAPTM4B_ A novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K_AKT signaling.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。